Dow Down 0.14% Nasdaq Up 0.19%

Theravance Inc. (THRX)

-NasdaqGS
22.02 Up 0.04(0.18%) 2:24PM EDT - Nasdaq Real Time Price
Prev Close:21.98
Open:22.00
Bid:21.97 x 400
Ask:22.02 x 500
1y Target Est:29.86
Beta:0.63
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:21.69 - 22.46
52wk Range:20.23 - 34.53
Volume:320,135
Avg Vol (3m):1,152,040
Market Cap:2.53B
P/E (ttm):N/A
EPS (ttm):-1.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
THRXUp 0.18%2.53B
AZNDown 0.05%92.39B
CBSTUp 1.77%5.00B
PFEUp 0.45%183.57B

Key Statistics

Forward P/E (1 yr):219.70
P/S (ttm):1,114.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.15
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback